Industrial careers. Palle Høy Jakobsen Director Head, R&D Academic Fellowships Novo Nordisk A/S

Similar documents
11. December 2017 Marianne Birkeland Kjær

novo nordisk R&D AT A GLANCE

The value of integrated reporting

Our future workforce. Flemming Dahl, Senior Vice President and Head of Quality, Novo Nordisk

2016 EFPIA Data Collection and Reporting Experience - Novo Nordisk A/S learnings

Slide 1. Welcome and introduction. Lars Rebien Sørensen President & CEO

Metabolism and diabetes

Slide 1. Investor presentation. Copenhagen 1 November 2018

Slide 1. Welcome and strategy update. Lars Fruergaard Jørgensen President and CEO

Slide 1. Investor presentation. Meet the Management London, 9 August 2018

Slide 1. International Operations update. Mike Doustdar EVP International Operations. YASMIN FIEDLER, Germany Yasmin has type 1 diabetes

Slide 1. Financial update and closing remarks. Jesper Brandgaard EVP and CFO. RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A

STRATEGIC PLAN

World Premier International Research Center (WPI) Initiative General Comments on FY2007 WPI Project Progress by Program Committee

Melanoma. Research Alliance. Fast-Forwarding a Cure for Deadly Skin Cancer

Metrology in pharmaceutical production

1 November, 2013 or earlier

NEWSLETTER June Summer greetings from Follicum

International Operations overview and strategy. Maziar Mike Doustdar EVP International Operations. Slide 1

Forensic Graduates Require Hard Science, Soft Skills

Chronic illness is a growing market for Novo Nordisk

Academic collaboration: Sweden Japan

National Rural Health Association: Internship Opportunities

Task Force Members: Mandy Lauw, Chairman Geoff Barnes, Immediate Past Chairman

Slide 1. Investor presentation. London 5 February 2019

Strategy Department of Psychology University of Copenhagen

Schulich Dentistry STRATEGIC PLAN Schulich School of Medicine & Dentistry, Western University

Championing patients every step of the way

Partnering for Growth

Who we are. We envision a world where high quality eye health and vision care is accessible to all people.

Boehringer Ingelheim BioXcellence. Producing Value. Global Contract Manufacturing Excellence

Singapore s Progress on GLP and MAD

ALL LIVES HAVE EQUAL VALUE

Shareholder Presentation Annual Meeting 2018

STRATEGIC PLAN

Agenda 2030: One Nation Labour s Plan for science Response from Alzheimer s Research UK

Digestive & Metabolic Diseases

Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC

A Strategic Roadmap for the PICARD Programme in 2020

The corporate responsibility for health in society

Oral semaglutide and production expansion. Henrik Wulff EVP Product Supply. Peter Kristensen SVP Global Development

Program Officer, Sub-Saharan Africa: Population & Reproductive Health

DEVELOPMENT OF PLATFORM INJECTION DEVICES ADDRESSING HUMAN FACTORS AT AN EARLY STAGE FOR DIFFERENT USER GROUPS

TREAT U is a spin-off from the University of Coimbra, founded in January 2010, and headquartered in Coimbra, Portugal.

OUR STRATEGIC PLAN

Collaboration between Ajinomoto and ASEAN countries based on umami research activities

Making Life Better COMMUNITY BENEFIT REPORT

Boston Scientific is advancing...

DIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC)

CREATING A DOHAD GLOBAL NETWORK: USING OTHER NETWORKS AS A MODEL

Brain research supported by the European Union

Program Priorities 2018

Managing & Aligning Lists of Chemicals of High Concern

Type 1 Diabetes (T1D) Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research

Jennifer E. Mason (803)

Establishing LCA in the Healthcare Sector

Introducing Patheon in Milton Park

Strategic Plan

Diabetes Fonds Fellowships

Parkinson s Institute and Clinical Center Appoints Anthony Santiago, M.D., Neurologist and Movement Disorders Specialist as Chief Medical Officer

What Services do Registered Dietitian Nutritionists (RDN) Provide?

Who we are. We envision a world where high quality eye health and vision care is accessible to all people.

PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM

Table of Contents. 1. About Solvay Solvay at a Glance Group Portfolio Transforming Solvay Solvay s Portfolio Upgrade 7

GN Store Nord Goldman Sachs European Medtech and Healthcare Services Conference. CEO GN ReSound, Mike van der Wallen September 3, 2008

Position Profile Chief Executive Officer Feeding America San Diego San Diego, CA

CANCER RESEARCH UK SPONSORSHIP OPPORTUNITIES

BARDA s Division of Chemical, Biological, Radiological and Nuclear Medical Countermeasures

Creating Shared Value and meeting our commitments

ESMO FELLOWSHIP PROGRAMME & LEADERS GENERATION PROGRAMME

Symposium Program. #CLEARsymposium17. lean-healthcare-research-symposium/

Opportunity Knocks: FDA/CDRH Medical Device Fellowship and External Expertise

Integrating Project Management Standards within Business Technology Management (BTM)

The Dual Hormonal Artificial Pancreas in Diabetes Management. Medical Innovation Day Challenge

New Developments and Regulatory Issues SLEEP AND CIRCADIAN RESEARCH. October 11-12, 2018 AGENDA

Towards a Sustainable Global Infrastructure for Medical Countermeasures

Sign Linguistics Training: An Alternative Approach to Deaf Education

Using the Mozambique National Quality Policy to Encourage Biomedical Research, Innovation, & Infrastructure Investment

Medpace, a pioneer in the development of therapeutics to treat metabolic disorders, is your first stop for compound development in lipid studies.

Slide 1. R&D strategy. Mads Krogsgaard Thomsen EVP and Chief Science Officer. ZIHAO LI AND HIS MOTHER BING HAN, China Zihao has haemophilia A

The more question you ask the more different answers you will get

R&D Status in Romania

Adding Value to the NHS, Health and Care, through Research Management, Support & Leadership

Scottish Clinical Leadership Fellowship About the SCLF

Orthopedics/Orthopedic Surgery CV #6002

AAENP 2017 YEAR IN REVIEW

FDA Approves New Novo Nordisk Treatment for Patients with Hemophilia

FRANKFURT SITE TOUR 2017

2015 Net Impact Conference

THE CARDIFF COMMITMENT TO YOUTH ENGAGEMENT AND PROGRESSION: REPORT OF DIRECTOR OF EDUCATION & LIFELONG LEARNING

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014

14414/15 AF/evt 1 DG G 3 C

BSc (Hons) Medical Physiology and Diagnostics

Slide 1. Jefferies 2014 Global Healthcare Conference 5-June Karsten Munk Knudsen CVP of Finance & IT at NNI

Financial, social and environmental performance. Our focus is our strength

PSYCHIATRY. THE POWER OFx. Experts. Experience. Execution. A Deeper Dive into Psychiatry. Scientifically-Driven Clinical Development

at a glance

SUGAR, OBESITY AND DIABETES THE OTHER GLOBAL FOOD CRISIS

First and foremost we have the world s largest privately funded biomedical research group investing about $8 billion in 2008.

ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE

Transcription:

Industrial careers Palle Høy Jakobsen Director Head, R&D Academic Fellowships Novo Nordisk A/S

A Mission Impossible? 10 Jan 2013 2 Career oppertunities. PRIVATE The pharmaceutical industry PUBLIC Universities

Novo Nordisk at a glance Introduction to the company Novo Nordisk is a global healthcare company with 90 years of innovation and leadership within: diabetes care insulin injection devices Thanks to dedicated research into proteins, Novo Nordisk also holds leading positions within: haemostasis management growth hormone therapy hormone replacement therapy

Protein engineering and formulation Protein drug delivery Large-scale biologics manufacturing Global commercial infrastructure A Mission Impossible? 10 Jan 2013 5 Novo Nordisk at a glance Therapeutic area Compounds and capabilities Strategic focus Diabetes Insulin and GLP-1 Expand leadership Obesity GLP-1 Establish presence Haemophilia Coagulation factors Expand portfolio Growth disorders Human growth hormone Achieve leadership Novo Nordisk Way

A Mission Impossible? 10 Jan 2013 6 The R&D Process (drugs & devices) Idea Pre-project Research Clinical Manufacturing Pre-clinical tests Clinical trials Phases 1-3 Product registration Preparing for launch Reaching the market Phase 4 trials

A Mission Impossible? 10 Jan 2013 7 Over 4,000 Novo Nordisk employees contribute to R&D value chain External collaborations Quality (Corporate Relations) Diabetes Research Unit (950) Device R&D (311) Biopharm Research Unit (563) External collaborations CMC Supply (1,057) CMC: Chemistry, Manufacturing, Control Global Development (893) Haemophilia R&D Portfolio (33) Regulatory Affairs (368) New Product Planning (Operations) R&D staffs (Strategic R&D) : 38 Regional CMR* offices staff: 973 Last updated: Q2 2012 Source: People data *Clinical Medical Regulatory

Global R&D A Mission Impossible? 10 Jan 2013 8 Denmark Seattle Princeton Beijing Bangalore CMR* regions: *CMR: Clinical Medical Regulatory North America (Princeton, NJ) Europe (Zürich) International Operations (Zürich) Japan/Korea (Tokyo) China (Beijing) Research & Development Denmark Beijing, China Seattle, WA, USA Princeton, NJ, USA Bangalore, India

A Mission Impossible? 10 Jan 2013 Slide no 9 Novo Nordisk R&D S T R Programme Science Talent Attraction & Recruitment Novo Scholarships Grant to write master thesis at Danish universities and Lund university Grant to Medical Research Year at Danish universities Co-funded PhD. fellowships Industrial PhD PhD Schools at Danish universities STAR International PhDs (foreign host university) PostDocs STAR Post Docs, For STAR PhDs and exceptionally qualified scientists incl. medical doctors www.novonordisk.com/star

STAR PostDoc Fellows 2013 Active and completed 1998 30 June 2013 Sigma Aldrich (SAFC) Loyola Toronto McGill Nottingham Vrije Linköping Karolinska Institutet Washington Manchester Uppsala Fudan Dublin Lund Stanford Kings College Setsunan, Osaka, Japan Santiago de Compostela San Francisco Justus-Liebig The Hebrew -Hadassah Tokyo Berkley Geneva Martin Luther Burnham Institut Medical Research Chapel Hill Princeton Harvard Consiglio Nazionale delle Ricerche Institute for Biomedicine and Health Science R&D locations Clinical Medical Regulatory Offices

Diversity fosters innovation A Mission Impossible? 10 Jan 2013 11

STAR fellowship postgraduate training 2013

STAR Symposium activities

Novo Nordisk STAR fellows Professional Qualifications Strong competences from active research environments International experience and networks Good publications (and PhD thesis) and/or patent applications Skills in new technologies High personal ambitions

Fellowship Programmes Talent Attraction Knowledge Transfer Long term Relations Support of Education System

Career paths in Novo Nordisk A Mission Impossible? 10 Jan 2013 16

How can I develop? A Mission Impossible? 10 Jan 2013 17

More information at novonordisk.com/careers

A Mission Impossible? 10 Jan 2013 19 Conclusions [ ] you can't connect the dots looking forward; you can only connect them looking backwards. So you have to trust that the dots will somehow connect in your future. Steve Jobs, Commencement address Stanford, June 2005 But you can increase the odds Work hard Diversify Follow your passion